drugset / Trial / NCT00518973

Trial of Quetiapine in Anorexia Nervosa

NCT00518973

RandomizedParallel-groupDouble-blindTreatment

Summary

This research study is being held at UCSD to determine whether the medication Quetiapine helps people suffering from anorexia nervosa by reducing core eating disorders symptoms. This study will see if the medication Quetiapine helps symptoms of anxiety, depression, and obsessionality, in addition to increasing BMI. Men and women between the ages of 18-65 and are currently suffering from anorexia nervosa are needed.

Timeline

Start
2006-07
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications